<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000626.v1.p1" parentStudy="phs000626.v1.p1" createDate="2013-06-13" modDate="2015-05-21">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>David Hafler, MD, MSc</td><td>Yale School of Medicine, New Haven, CT, USA</td></tr>
		<tr><td>Funding Source</td><td>CA1061-A-18</td><td>National Multiple Sclerosis Society, New York, NY, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>CD4+ cell transcriptional profiling by RNA sequencing</StudyNameEntrez>
	<StudyNameReportPage>CD4+ cell transcriptional profiling by RNA sequencing</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Control Set</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>We use next generation sequencing to investigate the different transcriptomes of closely related CD4+ T-cells from healthy human donors to elucidate the genetic programs that underlie their specialized immune functions. Six cell types were included: Regulatory T-cells (CD25hiCD127low/neg with &#62;95% FOXP3+ purity), regulatory T-cells activated using PMA/ionomycin, CD25-CD45RA+ (&#39;naive&#39; helper T-cells), CD25-CD45RO+ (&#39;memory&#39; helper T-cells), activated Th17 cells (&#62;98% IL17A+ purity) and activated IL17-CD4+ T-cells (called &#39;ThPI&#39;). Poly-T capture beads were used to isolate mRNA from total RNA, and fragment sizes of ~200 were sequenced from both ends on Illumina&#39;s genome analyzer. We confirm many of the canonical signature genes of T-cell populations, but also discover new genes whose expression is limited to specific CD4 T-cell lineages, including long non-coding RNAs. Additionally, we find that genes encoded at loci linked to multiple human autoimmune diseases are enriched for preferential expression upon T-cell activation, suggesting that an aberrant response to T-cell activation is fundamental to pathogenesis.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p><ul><li>Not suffering from autoimmune disorder.</li></ul></p> <p><ul><li>Overall healthy at time of blood draw.</li></ul></p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Immune System Processes"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>David Hafler, MD, MSc</AttName>
			<Institution>Yale School of Medicine, New Haven, CT, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>CA1061-A-18</AttName>
			<Institution>National Multiple Sclerosis Society, New York, NY, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>



</Study>

</Studies>

</GaPExchange>
